MedTrace Logo

Axillary Lymph Node Tattoo Marking Study

NCT04947917 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2024-01-23

No results posted yet for this study

Summary

This research study investigates if SpotTM ink can help breast surgeons retrieve sampled lymph node as well as or better than the standard clip and radioseed guidance methods.

The names of the novel study intervention involved in this study is:

* SpotTM ink tattooing

The names of the standard of care study interventions involved in this study are:

* Core needle biopsy and/or fine needle aspiration
* Surgical Removal of the Lymph Nodes via clip and radioseed guidance

Conditions

Interventions

PROCEDURE

SpotTM Tattoo Ink

Ink injection

Sponsors & Collaborators

Principal Investigators

  • Leah H Portnow, MD · Brigham and Women's Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-29
Primary Completion
2023-04-13
Completion
2023-04-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04947917 on ClinicalTrials.gov